Distinct Phyllosphere Microbiome of Wild Tomato Species in Central Peru upon Dysbiosis.

Plants are colonized by myriads of microbes across kingdoms, which affect host development, fitness, and reproduction. Hence, plant microbiomes have been explored across a broad range of host species, including model organisms, crops, and trees under controlled and natural conditions. Tomato is one of the world's most important vegetable crops; however, little is known about the microbiota of wild tomato species. To obtain insights into the tomato microbiota occurring in natural environments, we sampled epiphytic microbes from leaves of four tomato species, Solanum habrochaites, S. corneliomulleri, S. peruvianum, and S. pimpinellifolium, from two geographical locations within the Lima region of Peru over 2 consecutive years. Here, a high-throughput sequencing approach was applied to investigate microbial compositions including bacteria, fungi, and eukaryotes across tomato species and geographical locations. The phyllosphere microbiome composition varies between hosts and location. Yet, we identified persistent microbes across tomato species that form the tomato microbial core community. In addition, we phenotypically defined healthy and dysbiotic samples and performed a downstream analysis to reveal the impact on microbial community structures. To do so, we compared microbial diversities, unique OTUs, relative abundances of core taxa, and microbial hub taxa, as well as co-occurrence network characteristics in healthy and dysbiotic tomato leaves and found that dysbiosis affects the phyllosphere microbial composition in a host species-dependent manner. Yet, overall, the present data suggests an enrichment of plant-promoting microbial taxa in healthy leaves, whereas numerous microbial taxa containing plant pathogens occurred in dysbiotic leaves.Concluding, we identify the core phyllosphere microbiome of wild tomato species, and show that the overall phyllosphere microbiome can be impacted by sampling time point, geographical location, host genotype, and plant health. Future studies in these components will help understand the microbial contribution to plant health in natural systems and can be of use in cultivated tomatoes.

[Atorvastatin induced increase in homologous angiotensin I converting enzyme (ACE2) mRNA is associated to decreased fibrosis and decreased left ventricular hypertrophy in a rat model of diabetic cardiomyopathy]. / El aumento de la expresión del ARNm de la enzima convertidora de angiotensina I homóloga (ECA-2) inducido por atorvastatina se asocia a menor fibrosis e hipertrofia ventricular izquierda en un modelo de cardiomiopatía diabética.

OBJECTIVES: This study has investigated the effect of atorvastatin on the progression of cardiac remodelling and ACE- 2 expression in diabetic myocardium in rats. MATERIALS AND METHODS: Diabetes was induced in Holtzman rats with an intraperitoneal injection of streptozotocin. The animals were divided into 3 groups: (1) normal control rats, (2) diabetic rats and (3) diabetic rats treated orally with atorvastatin (50 mg/kg/day). After eight weeks of treatment, the hearts were removed for morphometric studies, collagen content assay and genetic expressions of ACE and ACE2 mRNA. RESULTS: Myocardial hypertrophy index and collagen deposition were increased in diabetic rats, but not in the treated-diabetic rats, without producing changes in cholesterol levels. Myocardial ACE mRNA levels were increased while ACE2 mRNA levels were decreased in diabetic rats. Atorvastatin administration attenuated overexpression of ACE mRNA and overexpression of ACE-2 mRNA in diabetic rats. CONCLUSIONS: Our results indicate that atorvastatin, independently of its cholesterol-lowering capacity, lowers the ACE/ACE2 ratio to normal values and attenuates the development of adverse remodeling in the diabetic heart.

El aumento de la expresión del ARNm de la enzima convertidora de angiotensina I homóloga (ECA-2) inducido por atorvastatina se asocia a menor fibrosis e hipertrofia ventricular izquierda en un modelo de cardiomiopatía diabética / Atorvastatin induced increase in homologous angiotensin i converting enzyme (ACE2) mRNA is associated to decreased fibrosis and decreased left ventricular hypertrophy in a rat model of diabetic cardiomyopathy

Objetivos. Evaluar el efecto de atorvastatina sobre la progresión del remodelado cardiaco y la expresión de ECA-2 en el miocardio de ratas diabéticas. Materiales y métodos. La diabetes fue inducida en ratas Holtzman con una inyección intraperitoneal de estreptozotocina. Los animales fueron divididos en tres grupos: (1) ratas control, (2) ratas diabéticas y (3) ratas diabéticas tratadas con atorvastatina (50 mg/kg/día). Después de ocho semanas de tratamiento, los corazones fueron extraídos para el análisis morfométrico, la cuantificación de colágeno y la determinación de los niveles de ARNm de ECA y ECA-2. Resultados. El índice de hipertrofia ventricular y el depósito de colágeno se incrementaron significativamente en las ratas diabéticas. La administración de atorvastatina previno estos cambios sin modificar los niveles de colesterol. La hiperglicemia produjo un incremento significativo en los niveles del ARNm de ECA y una marcada disminución en la expresión de ECA-2 en el miocardio de ratas diabéticas. La administración de atorvastatina indujo la expresión del ARNm de ECA-2 e inhibió la sobreexpresión del ARNm de ECA en el miocardio de las ratas diabéticas. Conclusiones. Nuestros resultados indican que la atorvastatina, independientemente de su capacidad para disminuir el colesterol, normaliza la relación de la expresión de ECA/ECA-2 y atenúa el desarrollo del remodelado adverso en el corazón diabético.

Objectives. This study has investigated the effect of atorvastatin on the progression of cardiac remodelling and ACE- 2 expression in diabetic myocardium in rats. Materials and Methods. Diabetes was induced in Holtzman rats with an intraperitoneal injection of streptozotocin. The animals were divided into 3 groups: (1) normal control rats, (2) diabetic rats and (3) diabetic rats treated orally with atorvastatin (50 mg/kg/day). After eight weeks of treatment, the hearts were removed for morphometric studies, collagen content assay and genetic expressions of ACE and ACE2 mRNA. Results. Myocardial hypertrophy index and collagen deposition were increased in diabetic rats, but not in the treated-diabetic rats, without producing changes in cholesterol levels. Myocardial ACE mRNA levels were increased while ACE2 mRNA levels were decreased in diabetic rats. Atorvastatin administration attenuated overexpression of ACE mRNA and overexpression of ACE-2 mRNA in diabetic rats. Conclusions. Our results indicate that atorvastatin, independently of its cholesterol-lowering capacity, lowers the ACE/ACE2 ratio to normal values and attenuates the development of adverse remodeling in the diabetic heart.

Disposición del conducto dentario inferior en el cuerpo mandibular: estudio anatómico y tomográfico / Location of the inferior dental canal within the mandibular body: anatomical and tomographic study

El objetivo del presente estudio fue determinar la distancia entre el conducto dentario inferior (CDI) y las tablas óseas lingual (TL), vestibular (TV) y basal (RB) en cuatro sectores del cuerpo mandibular. Se utilizaron diez mandíbulas que presentaban la región premolar y molar edéntula. Se evaluaron a través de tomografía espiral convencional (Cranex TOME multifuctional unit, Soredex, Finlandia) y en examen visual directo posterior a la osteotomía. Se realizaron mediciones desde el CDI hasta TL, TV y RB; a nivel del segundo premolar, primer molar, segunda molar y tercer molar. Los resultados obtenidos se evaluaron con las pruebas ANOVA, Kolmogorov-Smirnov y test de Levene que demostraron homogeneidad entre las medidas de los especimenes y las tomografías (p>0,05). Para referir las medidas se utilizó ANOVA y Kruskal-Wallis donde se encontró que el diámetro del CDI y la distancia hacia la TL eran constantes en los cuatro sectores del cuerpo mandibular (p>0,05). El diámetro del CDI presentó un rango de 2,3 mm a 2,6 mm y la distancia a TL de 2,5 mm a 2,8 mm. Las distancias a RB y TV presentaban diferencias estadísticamente significativas (p<0,05). El presente estudio demuestra que el diámetro del CDI en el cuerpo mandibular tiende ha ser constante y el CDI recorre el cuerpo mandibular con mayor proximidad a la TL.

The aim of the current study was determine the distance between mandibular canal (CDI) and the lingual (TL), labial (V) and basal cortical bone (RB) in four mandibular body areas. Ten mandibular bones showing premolar and molar edentulous region were used. They were assessedby Conventional Spiral Tomography (Cranex TOME multifuctional unit, Soredex, Finland) and a direct visual exam following osteotomy. Measures were made from CDI to TL, TV and RB? at second premolar, first molar, second molar and third molar level. The results were assessed by ANOVA, Kolmogorov-Smirnov and Levene tests that showed homogeneity among specimens measures and Tomographies (p>0.05). ANOVA and Kruskal-Wallis were used to refer measures where CDI diameter and the distance to TL were constant in the four mandibular body areas (p>0.05). CDI diameter showed a rank from 2.3mm to 2.6mm and a distance of 2.5mm a 2.8mm to TL. The distances to RB and TV showed statistically significant differences (p<0.05). The current study shows that CDI diameter remains constant and that CDI runs throught the mandibular body close to the TL.